Clinical Trials Browser

Phase 1/2 × IBIO123 × Lymphoid × Clear all

NCT05303376 2023-09-13

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

Phase 1/2 Completed

COVID-19, Lymphoma, Follicular, Respiratory Aspiration